BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31896594)

  • 1. Development of an Enterovirus 71 Vaccine Efficacy Test Using Human Scavenger Receptor B2 Transgenic Mice.
    Imura A; Sudaka Y; Takashino A; Tamura K; Kobayashi K; Nagata N; Nishimura H; Mizuta K; Koike S
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
    In HJ; Lim H; Lee JA; Kim HJ; Kim JW; Hyeon JY; Yeo SG; Lee JW; Yoo JS; Choi YK; Lee SW
    PLoS One; 2017; 12(5):e0178259. PubMed ID: 28542556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.
    Premanand B; Prabakaran M; Kiener TK; Kwang J
    PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.
    Lei D; Griffiths E; Martin J
    Vaccine; 2020 Jul; 38(32):4917-4923. PubMed ID: 32418797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease.
    Ong KC; Devi S; Cardosa MJ; Wong KT
    J Virol; 2010 Jan; 84(1):661-5. PubMed ID: 19864378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence.
    Chang CK; Wu SR; Chen YC; Lee KJ; Chung NH; Lu YJ; Yu SL; Liu CC; Chow YH
    Sci Rep; 2018 Apr; 8(1):6688. PubMed ID: 29703921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development.
    Chia MY; Chung WY; Chiang PS; Chien YS; Ho MS; Lee MS
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e3044. PubMed ID: 25058733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
    Hwa SH; Lee YA; Brewoo JN; Partidos CD; Osorio JE; Santangelo JD
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2538. PubMed ID: 24244774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development.
    Chang PC; Chen SC; Chen KT
    Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27618078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of Enterovirus A71 Empty and Full Particles by Sedimentation Velocity Analytical Ultracentrifugation.
    Yang A; Luo Y; Yang J; Xie T; Wang W; Wan X; Wang K; Pang D; Yang D; Dai H; Wu J; Meng S; Guo J; Wang Z; Shen S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterovirus 71 Activates Plasmacytoid Dendritic Cell-Dependent PSGL-1 Binding Independent of Productive Infection.
    Zhang X; Yin Z; Zhang J; Guo H; Li J; Nie X; Wang S; Zhang L
    J Immunol; 2024 Jun; 212(11):1782-1790. PubMed ID: 38629901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection.
    Lin HY; Yang YT; Yu SL; Hsiao KN; Liu CC; Sia C; Chow YH
    J Virol; 2013 Aug; 87(16):9064-76. PubMed ID: 23760234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.
    Lee BY; Wateska AR; Bailey RR; Tai JH; Bacon KM; Smith KJ
    Vaccine; 2010 Nov; 28(49):7731-6. PubMed ID: 20923711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice.
    Li X; Liu Z; Yan X; Tian Y; Liu K; Zhao Y; Shao J; Hao P; Zhang C
    PLoS Pathog; 2023 Oct; 19(10):e1011662. PubMed ID: 37788227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
    Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclin1 Binds to Enterovirus 71 3D Protein to Promote the Virus Replication.
    Xiang Q; Wan P; Yang G; Huang S; Qin M; Yang H; Luo Z; Wu K; Wu J
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32674313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EV71 virus reduces Nrf2 activation to promote production of reactive oxygen species in infected cells.
    Bai Z; Zhao X; Li C; Sheng C; Li H
    Gut Pathog; 2020; 12():22. PubMed ID: 32346399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
    Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
    Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
    Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular receptors for enterovirus A71.
    Kobayashi K; Koike S
    J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.